Evidence map›Paper›PMID 40007721›Full record

ArticleAnnals of Ibadan postgraduate medicine2024

OBESITY & HYPERTENSION - 'TWO PEAS IN A POD'.

A O Akanji

Abstract read
In one paragraph

Article in Annals of Ibadan postgraduate medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A O AkanjiDepartment of Medical Sciences, Frank H Netter, MD, School of Medicine, Quinnipiac University, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a global epidemic of obesity and hypertension. These two relatively common disorders derive from a basic underlying pathophysiologic abnormality, like 'two peas in a pod' There is a consensus that obesity predicts the future development of hypertension and that the relationship between blood pressure and body weight is linear independent of gender, age, and socioeconomic status. This brief commentary outlines the pathogenetic mechanisms for the obesity-hypertension association. These mechanisms are likely complex, multifactorial, and polygenic with possible roots in early ontogeny. A unifying hypothesis should integrate food intake and excess (resulting in weight gain) with increased sympathetic nervous activity (resulting in increased blood pressure). The adipokine, leptin, appears well suited to fill that role - its hypothalamic signaling pathways and neurovascular outcomes are therefore explored in some detail. An understanding of these relationships from the perspectives of both epidemiology and pathophysiology is crucial to the management of both disorders - obesity with hypertension - and particularly more so in developing countries that lack the resources to deal with the looming epidemic of atherosclerotic cardiovascular disease.

Indexed as

HypertensionLeptinMetabolic syndromeObesitySympathetic nervous system.

Identifiers

PMID40007721
PMCPMC11848363

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.